Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.

Research into treatment and prevention

The Masonic Charitable Foundation awards research grants in recognition of the increasing need for improved treatments and prevention as our population ages.

Stroke and dementia are the two leading causes of neurological disability in the developed world and are the most costly in terms of health and social care. Reducing this burden requires more effective prevention, which is likely to be best achieved by studying both conditions in parallel.

The Centre for the Prevention of Stroke and Dementia (CPSD) has published over 400 research papers since 2000, and received the Queen’s Anniversary Prize for Higher Education in 2014 in recognition of impact on healthcare. It focuses mainly on clinical research with patients. By joining up NHS clinical care and research in the university we are able to provide answers to those questions that are of most immediate importance to patients, their families, and their clinicians.

CPSD is now housed in the new Wolfson Building on the John Radcliffe site, which provides the opportunity to expand research and to introduce new DPhil studentships. CPSD has an excellent track record of training research fellows, with over 30 successful DPhil or equivalent students over the last 15 years. DPhil projects usually involve one of CPSD's four main programmes to improve diagnosis, prognostication and targeting of treatment to prevent stroke and vascular dementia.


Similar stories

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.

New book on global anaesthesia

Hilary Edgcombe, with two colleagues in other centres, has co-edited a new Oxford Handbook addressing safe anaesthesia in resource-limited settings

Our researchers test ‘Viagra’ drug to prevent recurrent strokes

Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.

NDCN staff win teaching awards

The 2019 MSD Teaching Excellence Awards were celebrated in a ceremony at Merton College on Wednesday 23 October.

Oxford partners with Quinnipiac to improve neuro-rehabilitation

The delivery of clinical care, research, and education in neuro-rehabilitation in Oxford will be revolutionised by an innovative partnership with Quinnipiac University, Hartford, USA.

Risk of dementia after TIA or stroke

Risk of dementia after stroke is a major concern for patients and carers. Reliable data on risk of dementia, particularly after TIA or minor stroke, are scarce.